Rationale for Strengthening Muscle to Prevent Falls and Fractures: A Review of the Evidence.
Identifieur interne : 001D30 ( PubMed/Curation ); précédent : 001D29; suivant : 001D31Rationale for Strengthening Muscle to Prevent Falls and Fractures: A Review of the Evidence.
Auteurs : Olivier Benichou [France] ; Stephen R. Lord [Australie]Source :
- Calcified tissue international [ 1432-0827 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
- physiologie : Force musculaire.
- usage thérapeutique : Anabolisants.
- Chutes accidentelles, Entraînement en résistance, Force musculaire, Humains.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Anabolic Agents.
- drug effects : Muscle Strength.
- methods : Resistance Training.
- physiology : Muscle Strength.
- prevention & control : Accidental Falls.
- Humans.
Abstract
Falls represent a major public health problem in older people, predominantly due to the resulting injuries which lead to progressive disability, immobilization and resulting comorbidities, dependency, institutionalization, and death. Reduced muscle strength and power have been consistently identified as risk factors for falls and related injuries, and it is likely these associations result from the central role played by reduced muscle strength and power in poor balance recovery. In addition, muscle strength and power are involved with protective responses that reduce the risk of an injury if a fall occurs. Progressive resistance training (PRT) is the standard way to increase muscle strength and power, and this training forms one of the main components of fall prevention exercise interventions. However, PRT has rarely been implemented in routine practice due to multiple challenges inherent to frail older people. The ongoing development of drugs expected to increase muscle power offers a new opportunity to reduce the risk of falls and fall-related injuries. The intent here is not to replace exercise training with drugs but rather to offer a pharmacologic alternative when exercise is not possible or contraindicated. The target population would be those most likely to benefit from this mechanism of action, i.e., weak older people without major causes for falls independent of muscle weakness. Provided such a tailored strategy was followed, a muscle anabolic may address this major unmet need.
DOI: 10.1007/s00223-016-0107-9
PubMed: 26847435
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001D54
Links to Exploration step
pubmed:26847435Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rationale for Strengthening Muscle to Prevent Falls and Fractures: A Review of the Evidence.</title><author><name sortKey="Benichou, Olivier" sort="Benichou, Olivier" uniqKey="Benichou O" first="Olivier" last="Benichou">Olivier Benichou</name><affiliation wicri:level="1"><nlm:affiliation>Eli Lilly and Company, 24, Boulevard Vital-Bouhot, 92200, Neuilly, France. benichouol@lilly.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Eli Lilly and Company, 24, Boulevard Vital-Bouhot, 92200, Neuilly</wicri:regionArea></affiliation></author><author><name sortKey="Lord, Stephen R" sort="Lord, Stephen R" uniqKey="Lord S" first="Stephen R" last="Lord">Stephen R. Lord</name><affiliation wicri:level="1"><nlm:affiliation>NeuRA, UNSW, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>NeuRA, UNSW, Sydney, NSW</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26847435</idno><idno type="pmid">26847435</idno><idno type="doi">10.1007/s00223-016-0107-9</idno><idno type="wicri:Area/PubMed/Corpus">001D54</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D54</idno><idno type="wicri:Area/PubMed/Curation">001D30</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001D30</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Rationale for Strengthening Muscle to Prevent Falls and Fractures: A Review of the Evidence.</title><author><name sortKey="Benichou, Olivier" sort="Benichou, Olivier" uniqKey="Benichou O" first="Olivier" last="Benichou">Olivier Benichou</name><affiliation wicri:level="1"><nlm:affiliation>Eli Lilly and Company, 24, Boulevard Vital-Bouhot, 92200, Neuilly, France. benichouol@lilly.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Eli Lilly and Company, 24, Boulevard Vital-Bouhot, 92200, Neuilly</wicri:regionArea></affiliation></author><author><name sortKey="Lord, Stephen R" sort="Lord, Stephen R" uniqKey="Lord S" first="Stephen R" last="Lord">Stephen R. Lord</name><affiliation wicri:level="1"><nlm:affiliation>NeuRA, UNSW, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>NeuRA, UNSW, Sydney, NSW</wicri:regionArea></affiliation></author></analytic><series><title level="j">Calcified tissue international</title><idno type="eISSN">1432-0827</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Accidental Falls (prevention & control)</term><term>Anabolic Agents (therapeutic use)</term><term>Humans</term><term>Muscle Strength (drug effects)</term><term>Muscle Strength (physiology)</term><term>Resistance Training (methods)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anabolisants (usage thérapeutique)</term><term>Chutes accidentelles ()</term><term>Entraînement en résistance ()</term><term>Force musculaire ()</term><term>Force musculaire (physiologie)</term><term>Humains</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anabolic Agents</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Muscle Strength</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Resistance Training</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Force musculaire</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Muscle Strength</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Accidental Falls</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anabolisants</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Chutes accidentelles</term><term>Entraînement en résistance</term><term>Force musculaire</term><term>Humains</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Falls represent a major public health problem in older people, predominantly due to the resulting injuries which lead to progressive disability, immobilization and resulting comorbidities, dependency, institutionalization, and death. Reduced muscle strength and power have been consistently identified as risk factors for falls and related injuries, and it is likely these associations result from the central role played by reduced muscle strength and power in poor balance recovery. In addition, muscle strength and power are involved with protective responses that reduce the risk of an injury if a fall occurs. Progressive resistance training (PRT) is the standard way to increase muscle strength and power, and this training forms one of the main components of fall prevention exercise interventions. However, PRT has rarely been implemented in routine practice due to multiple challenges inherent to frail older people. The ongoing development of drugs expected to increase muscle power offers a new opportunity to reduce the risk of falls and fall-related injuries. The intent here is not to replace exercise training with drugs but rather to offer a pharmacologic alternative when exercise is not possible or contraindicated. The target population would be those most likely to benefit from this mechanism of action, i.e., weak older people without major causes for falls independent of muscle weakness. Provided such a tailored strategy was followed, a muscle anabolic may address this major unmet need.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26847435</PMID><DateCreated><Year>2016</Year><Month>05</Month><Day>09</Day></DateCreated><DateCompleted><Year>2017</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0827</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Calcified tissue international</Title><ISOAbbreviation>Calcif. Tissue Int.</ISOAbbreviation></Journal><ArticleTitle>Rationale for Strengthening Muscle to Prevent Falls and Fractures: A Review of the Evidence.</ArticleTitle><Pagination><MedlinePgn>531-45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00223-016-0107-9</ELocationID><Abstract><AbstractText>Falls represent a major public health problem in older people, predominantly due to the resulting injuries which lead to progressive disability, immobilization and resulting comorbidities, dependency, institutionalization, and death. Reduced muscle strength and power have been consistently identified as risk factors for falls and related injuries, and it is likely these associations result from the central role played by reduced muscle strength and power in poor balance recovery. In addition, muscle strength and power are involved with protective responses that reduce the risk of an injury if a fall occurs. Progressive resistance training (PRT) is the standard way to increase muscle strength and power, and this training forms one of the main components of fall prevention exercise interventions. However, PRT has rarely been implemented in routine practice due to multiple challenges inherent to frail older people. The ongoing development of drugs expected to increase muscle power offers a new opportunity to reduce the risk of falls and fall-related injuries. The intent here is not to replace exercise training with drugs but rather to offer a pharmacologic alternative when exercise is not possible or contraindicated. The target population would be those most likely to benefit from this mechanism of action, i.e., weak older people without major causes for falls independent of muscle weakness. Provided such a tailored strategy was followed, a muscle anabolic may address this major unmet need.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benichou</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3178-9046</Identifier><AffiliationInfo><Affiliation>Eli Lilly and Company, 24, Boulevard Vital-Bouhot, 92200, Neuilly, France. benichouol@lilly.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lord</LastName><ForeName>Stephen R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>NeuRA, UNSW, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Calcif Tissue Int</MedlineTA><NlmUniqueID>7905481</NlmUniqueID><ISSNLinking>0171-967X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D045930">Anabolic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000058" MajorTopicYN="N">Accidental Falls</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045930" MajorTopicYN="N">Anabolic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055070" MajorTopicYN="N">Resistance Training</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Balance</Keyword><Keyword MajorTopicYN="N">Fall</Keyword><Keyword MajorTopicYN="N">Fracture</Keyword><Keyword MajorTopicYN="N">Injury</Keyword><Keyword MajorTopicYN="N">Muscle</Keyword><Keyword MajorTopicYN="N">Power</Keyword><Keyword MajorTopicYN="N">Strength</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26847435</ArticleId><ArticleId IdType="doi">10.1007/s00223-016-0107-9</ArticleId><ArticleId IdType="pii">10.1007/s00223-016-0107-9</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D30 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001D30 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:26847435
|texte= Rationale for Strengthening Muscle to Prevent Falls and Fractures: A Review of the Evidence.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:26847435" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |